

The financial success of Vonau Flash is due to two outstanding features: it does not cause sleepiness and it dissolves in the mouth. Why has Vonau been such a success for USP?

Data from Auspin show that royalties earned through exploitation contracts reached BRL 3.44 million in 2018, with Vonau leading all other products. The university currently has 1,299 patents involving technologies and/or products developed by different departments. In other words, the result of a single research study is generating more money than all the other patents owned by USP. That statistic was provided by Professor Marcos Martins, coordinator of the university's innovation agency, Auspin. Have you heard of the Vonau Flash? It is a medication whose patent was awarded to USP last year, and which has become its largest ever source of royalties (payments received for the right to sell a product), accounting for approximately 90% of the fees earned by the university to date. Well, you should know that one of these studies conducted by the University of São Paulo (USP) found the "solution" to nausea and vomiting and has brought a return of around BRL 10 million in the last 13 years. Many people assume that research studies conducted by Brazil's public universities are of no practical use.
